173 related articles for article (PubMed ID: 16841077)
41. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
42. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
43. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
[TBL] [Abstract][Full Text] [Related]
44. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.
Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Duara R
Am J Geriatr Psychiatry; 1999; 7(2):119-23. PubMed ID: 10322238
[TBL] [Abstract][Full Text] [Related]
46. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
Irie F; Masaki KH; Petrovitch H; Abbott RD; Ross GW; Taaffe DR; Launer LJ; White LR
Arch Gen Psychiatry; 2008 Aug; 65(8):906-12. PubMed ID: 18678795
[TBL] [Abstract][Full Text] [Related]
47. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
48. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
49. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
[TBL] [Abstract][Full Text] [Related]
51. Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.
De Luca V; Orfei MD; Gaudenzi S; Caltagirone C; Spalletta G
Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):599-606. PubMed ID: 26714935
[TBL] [Abstract][Full Text] [Related]
52. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
53. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
54. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
55. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
56. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
[TBL] [Abstract][Full Text] [Related]
57. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
58. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
59. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
[TBL] [Abstract][Full Text] [Related]
60. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.
Combarros O; Leno C; Oterino A; Berciano J; Fernández-Luna JL; Fernández-Viadero C; Peña N; Miró J; Delgado M
Acta Neurol Scand; 1998 Jan; 97(1):68-71. PubMed ID: 9482681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]